Keyphrases
Aging
17%
Alveolar Soft Part Sarcoma
14%
Buccal Bifurcation Cyst
14%
C-C Chemokine Receptor Type 5 (CCR5)
21%
Cancer Therapy
14%
Carcinoma
14%
CCL5
21%
CD31
17%
Cervical Lymph Node Metastasis
14%
Chemokine Receptor CCR5 Antagonists
14%
Chemokine Receptor CXCR4
14%
Chile
35%
CXCR4 Antagonist
14%
Displasia
14%
Epidermal Growth Factor Receptor Expression
14%
Gastric Syphilis
14%
Genetic Profile
14%
Gingival
14%
HIV-associated
14%
Immunoexpression
28%
Immunohistochemistry
19%
Intraosseous
21%
Latin America (LATAM)
15%
Latin American Studies
14%
Malonic Acid
18%
Mandible
35%
Mandibular Ramus
19%
Masseter
14%
Masson's Trichrome Stain
14%
Mean Vascular Density
28%
Metastasis
21%
Normal Oral mucosa
42%
Odontogenic Tumors
30%
Oral Epithelial Dysplasia
39%
Oral Health-related Quality of Life (OHRQoL)
22%
Oral Lesions
31%
Oral Tongue Squamous Cell Carcinoma (OTSCC)
100%
Patient Well-being
16%
Perineural Invasion
14%
Poor Survival
15%
Randomized Controlled Clinical Trial
14%
Salivary Gland Tumor
14%
South America
20%
Systemic Lupus Erythematosus
14%
Therapeutic Perspectives
14%
Tumor
16%
Vimentin
19%
Vitamin E
14%
White Plaque
14%
Xerostomia
28%
Medicine and Dentistry
Alveolar Soft Part Sarcoma
14%
Benign Tumor
10%
Cancer Therapy
14%
Carcinoma
14%
Cellular Senescence
14%
Cervical Lymph Node Metastasis
14%
Chemokine Receptor CCR5 Antagonist
19%
Chemokine Receptor CXCR4
14%
Chemokine Receptor CXCR4 Antagonist
14%
Clinician
14%
Controlled Clinical Trial
14%
Cowden Syndrome
14%
Desmoplastic Fibroma
28%
Disease
17%
Epidermal Growth Factor Receptor
14%
Epithelial Dysplasia
42%
Genodermatosis
14%
Gum (Oral Cavity)
14%
Human Immunodeficiency Virus
19%
Immunohistochemistry
13%
Keratosis
14%
Linear Scleroderma
14%
Lower Jaw
35%
Malic Acid
17%
Malignant Neoplasm
22%
Maraviroc
14%
Masson's Trichrome Stain
14%
Maxilla
10%
Metastatic Carcinoma
19%
Morphea
14%
Mouth Lesion
28%
Mouth Squamous Cell Carcinoma
85%
Neoplasm
39%
Oral Cancer
9%
Oral Mucosa
29%
Perineural Invasion
14%
Peripheral Nerve Injury
14%
Plexiform Neurofibroma
14%
Prevalence
23%
Quality of Life
20%
Receptor Expression
14%
Salivary Gland Neoplasm
14%
Syphilis
14%
Systemic Lupus Erythematosus
14%
Tongue
12%
Trichrome
14%
Tumor Microenvironment
9%
Wart Virus
14%
Xanthoma
14%
Xerostomia
28%